RemediumOne

RemediumOne has expertise in disorders that affect the brain, such as stroke. RemediumOne’s neurological investigator networks have been cultivated over many years by participating in some of the world’s largest clinical neurology research trials, including the largest ever acute ischemic stroke trial.

Stroke is the second leading cause of death worldwide and is expected to worsen as society ages. In Asia, changes in
lifestyle and diet have led to a marked increase in the prevalence of stroke, particularly ischemic stroke.

RemediumOne has supported the work of The George Institute for Global Health in reducing the worldwide burden of neurological diseases by implementing a number of high-impact clinical trials.
RemediumOne collaborates with scientific leaders who are regularly called upon to develop new strategies for global decision-makers on how neurological medicine is practiced.

Our team of experts includes clinical research associates, project managers, regulatory affairs specialists, and medical monitors who possess a deep understanding of the unique challenges that come with conducting clinical trials in the field of neurology. Additionally, we have access to a wide network of tertiary-care hospitals around the country, enabling us to facilitate a variety of neurological clinical trials in Sri Lanka.

RemediumOne is committed to reducing the impact of neurological and mental health issues worldwide. We do this by studying what we already know, conducting important research, and coming up with new ways to improve medical practices in this field. Our goal is to make a positive difference in the lives of those affected by these conditions.